lactoferrin and bpc 157 Nutraceuticals & Cosmeceuticals | Family Healthcare of Lake Norman BPC-157 – Alphaceuticals by Dr.

DSIP + GHK-Cu Investigated for combined recovery and restorative sleep-cycle support

SS-31 10mg Vial Best for: Short-term protocols (2-4 weeks) or testing tolerance Reconstitution: 1.0 mL bacteriostatic water 10 mg/mL concentration Dosing at 10 mg/mL: 1 unit = 0.01 mL = 100 mcg 10 mg dose: 100 units (1.0 mL) Vials needed for 8 weeks @ 10mg/day: 50 vials SS-31 30mg Vial Best for: Standard 8-12 week protocols Reconstitution: 3.0 mL bacteriostatic water ~10 mg/mL concentration Dosing at 10 mg/mL: 1 unit = 0.01 mL = 100 mcg 10 mg dose: 100 units (1.0 mL) Vials needed for 8 weeks @ 10mg/day: 17 vials SS-31 50mg Vial Best for: Extended protocols or costeffective bulk research Reconstitution: 3.0 mL bacteriostatic water ~16.67 mg/mL concentration Dosing at 16.67 mg/mL: 1 unit = 0.01 mL 167 mcg 10 mg dose: 60 units (0.60 mL) Vials needed for 8 weeks @ 10mg/day: 10 vials Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing across all vial sizes Standard / Gradual Approach Frequency: Inject once daily subcutaneously at a consistent time

We serve patients throughout Naples and Collier County who are seeking advanced therapeutic options to support healing, joint health, performance, and recovery

In 2004, it was reported that subcutaneous (s.c.) administration of the BPC 157 peptide to rats (10 g/kg/day for 7 days) resulted in brain region-specific increases in serotonin synthesis [99], as determined by the precise alpha-[14C]methyl-L-tryptophan (alpha-MTrp) autoradiographic method